#san_sebastián
EpilepsyGTx and Viralgen Join Forces to Advance Innovative Gene Therapy for Epilepsy#USA#gene_therapy#San_Sebastián#Viralgen#EpilepsyGTx
EpilepsyGTx and Viralgen Join Forces to Advance Innovative Gene Therapy for Epilepsy
EpilepsyGTx and Viralgen are collaborating on a gene therapy program aimed at treating refractory epilepsy with promising human trials approaching.
third-news.com
September 9, 2026 at 1:04 PM
EpilepsyGTx and Viralgen Launch Collaborative Gene Therapy Program for Refractory Epilepsy#USA#San_Sebastián#Viralgen#EpilepsyGTx#AAV_vectors
EpilepsyGTx and Viralgen Launch Collaborative Gene Therapy Program for Refractory Epilepsy
EpilepsyGTx and Viralgen collaborate on gene therapy using AAV vectors to advance treatment for refractory epilepsy, affecting millions worldwide.
third-news.com
September 9, 2026 at 10:14 AM
EpilepsyGTx and Viralgen Unite to Propel Gene Therapy for Epilepsy Toward Clinical Trials#USA#gene_therapy#San_Sebastián#Viralgen#EpilepsyGTx
EpilepsyGTx and Viralgen Unite to Propel Gene Therapy for Epilepsy Toward Clinical Trials
EpilepsyGTx partners with Viralgen to push their AAV gene therapy, EPY201, aimed at treating refractory epilepsy, into human trials, supporting millions.
third-news.com
September 9, 2026 at 8:10 AM
EpilepsyGTx and Viralgen Join Forces for Advanced Gene Therapy in Epilepsy Treatment#USA#gene_therapy#San_Sebastián#Viralgen#EpilepsyGTx
EpilepsyGTx and Viralgen Join Forces for Advanced Gene Therapy in Epilepsy Treatment
EpilepsyGTx and Viralgen are collaborating to advance a specialized AAV gene therapy aimed at epilepsy, promising innovative treatment options for patients worldwide.
third-news.com
September 9, 2026 at 8:09 AM
Viralgen and Elaaj Bio Join Forces to Enhance Gene Therapy for CDKL5 Deficiency Disorder#Spain#San_Sebastián#Viralgen#CDKL5#Elaaj_Bio
Viralgen and Elaaj Bio Join Forces to Enhance Gene Therapy for CDKL5 Deficiency Disorder
In a pivotal collaboration, Viralgen and Elaaj Bio align their expertise to drive the development of innovative gene therapy targeting CDKL5 deficiency disorder, aiming for clinical advancement.
third-news.com
May 5, 2026 at 1:26 PM
Viralgen Partners with Elaaj Bio to Accelerate Gene Therapy for CDKL5 Deficiency Disorder#USA#Viralgen#CDKL5_Deficiency#Elaaj_Bio#San_Sebastián,_Spain
Viralgen Partners with Elaaj Bio to Accelerate Gene Therapy for CDKL5 Deficiency Disorder
Viralgen collaborates with Elaaj Bio to enhance a gene therapy program for CDKL5 deficiency disorder, a rare neurological condition affecting children.
third-news.com
May 5, 2026 at 1:23 PM
Experience the Finest Spanish Cuisine at 'TOKYO MEETS SAN SEBASTIAN 2025' Fair in Tokyo#Japan#Tokyo#San_Sebastián#Hotel_Maria_Cristina#Chef_Stefano_Brunato
Experience the Finest Spanish Cuisine at 'TOKYO MEETS SAN SEBASTIAN 2025' Fair in Tokyo
Indulge in an exclusive Spanish culinary experience in Tokyo with the 'TOKYO MEETS SAN SEBASTIAN 2025' fair featuring the renowned Chef Stefano Brunato.
third-news.com
September 16, 2025 at 11:32 AM
San Sebastián, Puerto Rico
Population: 8,490
Photos from Google Places API
Link: https://en.wikipedia.org/wiki/San_Sebastián,_Puerto_Rico
June 3, 2025 at 5:29 PM
Viralgen Partners with Trogenix to Propel AAV Gene Therapy for Glioblastoma#Spain#San_Sebastián#Viralgen#AAV_Gene_Therapy#Trogenix
Viralgen Partners with Trogenix to Propel AAV Gene Therapy for Glioblastoma
Viralgen joins forces with Trogenix to advance AAV gene therapy for glioblastoma, enhancing manufacturing and accelerating clinical trials.
third-news.com
May 6, 2025 at 2:05 PM
Innovative Gene Therapy for CTNNB1 Syndrome: A Partnership by Viralgen and CTNNB1 Foundation#Spain#San_Sebastián#Viralgen#CTNNB1_Syndrome#CTNNB1_Foundation
Innovative Gene Therapy for CTNNB1 Syndrome: A Partnership by Viralgen and CTNNB1 Foundation
Viralgen has teamed up with the CTNNB1 Foundation to create a groundbreaking gene therapy for CTNNB1 Syndrome, promising hope to patients worldwide.
third-news.com
February 5, 2025 at 1:47 PM
Viralgen and Axovia Join Forces for Gene Therapy Development for Retinal Dystrophy#Spain#San_Sebastián#Viralgen#Axovia#BBS
Viralgen and Axovia Join Forces for Gene Therapy Development for Retinal Dystrophy
Viralgen and Axovia are collaborating to manufacture an investigational gene therapy targeting retinal dystrophy in Bardet-Biedl Syndrome patients.
third-news.com
January 22, 2025 at 3:02 PM
Ach, Donostia, vor 2 Wochen bin ich noch durch Deine Altstadt gelaufen. Jetzt vermiss ich Dich schon. #San_Sebastián
December 1, 2024 at 12:04 PM
#San_Sebastián, es war wieder einmal großartig. Zum 21. Mal in Folge war ich hier und nächstes Jahr komme ich wieder.
December 1, 2024 at 11:48 AM
Wie wahnsinnig schön #San_Sebastián ist, sieht man auch ganz gut von oben, auf Google Maps: https://goo.gl/maps/kcpAGhVa4dJ2
December 1, 2024 at 11:46 AM